通过氧化来控制IFN-γ介导的SARS-CoV-2感染
Bruno J de Andrade Silva1, Paul A Krogstad2,3, Rosane M B Teles1
1Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California (UCLA), Los Angeles, CA, United States.
Frontiers in immunology
|January 1, 2024
概括
干扰素- (IFN-γ) 通过氧化 (NO) 生产在肺细胞中触发了对SARS-CoV-2的抗病毒防御. 这种不依赖NO的机制对宿主防御至关重要,并可能为COVID-19提供治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 细胞生物学 细胞生物学
背景情况:
- 随着COVID-19的流行,我们需要了解宿主对SARS-CoV-2的防御机制.
- 干扰素- (IFN-γ) 在清除SARS-CoV-2和解决肺部症状方面表现有前途.
- 在肺上皮细胞中IFN-γ的抗病毒活性的确切机制仍未确定.
研究的目的:
- 调查IFN-γ在人类肺上皮细胞中对SARS-CoV-2的抗病毒活性是否依赖于氧化 (NO) 的产生.
- 探索诱导性氧化合成酶 (iNOS) 在这种NO介导抗病毒反应中的作用.
- 评估白蛋白-1β (IL-1β) 对IFN-γ诱导的NO产生和抗病毒功效的影响.
主要方法:
- 使用IFN-γ.治疗Vero E6,A549-ACE2和Calu-3细胞系.
- 对NO诱导和SARS-CoV-2复制的测量.
- 药理上抑制iNOS以确定NO依赖性.
- 评估IL-1β对IFN-γ诱导的NO和抗病毒活性的影响.
主要成果:
- IFN-γ剂量反应诱导NO,并抑制了Vero E6细胞中的SARS-CoV-2复制.
- 抑制iNOS阻断了抗病毒作用,证实了NO的依赖性.
- 在人类肺细胞系 (A549-ACE2,Calu-3) 中通过NO.通过IFN-γ介导的抗病毒活性对抗SARS-CoV-2.
- IL-1β增强了IFN-γ诱导的NO产生,但对抗病毒功效的影响很小.
结论:
- IFN-γ在人类肺上皮细胞中触发了对SARS-CoV-2的NO依赖的先天抗病毒途径.
- 这一发现将自适应性免疫反应 (来自CD8+ T细胞的IFN-γ) 与先天性抗病毒防御联系起来.
- 强调IFN-γ和NO在抗病毒反应和潜在的COVID-19治疗方法中的重要性.
更多相关视频
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
12.9K
10:10Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
13.6K
相关概念视频
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
